The more you know about End-Stage AMD, the easier it is to understand the CentraSight treatment program. End-Stage AMD is a disease of the retina. It is the most advanced form of age-related macular degeneration (AMD) and the leading cause of irreversible vision loss and legal blindness in individuals over the age of 65.
Some degeneration of the macula is normal during aging. In early, less advanced AMD, visual symptoms are generally mild and may or may not impact vision-related activities. However, advanced stages of AMD can result in severe loss of sight in the central part of vision. This is often referred to as a central vision "blind spot". This blind spot is different than the visual disturbances experienced with cataracts (clouding of the eye's lens) and is not correctable by cataract surgery or eyeglasses. Side vision, or peripheral vision, is not affected by AMD, but is too low resolution (blurry) to make up for lost central vision.
With End-Stage AMD, the macula reaches a point where central vision is lost in both eyes, making it difficult to perform everyday tasks. End-Stage AMD can develop from the dry form of AMD or the fast-progressing wet form. There are no drugs or treatments that can cure End-Stage AMD. The damage to the macula is permanent.